At the EAACI 2026 conference, dupilumab demonstrated superior outcomes over omalizumab in patients with severe asthma characterised by high biomarker levels.
Category: Health & Science
Cannabis Psychosis Shows Distinct Symptom Pattern Separate From Schizophrenia
A new study published in 2026 found that cannabis-induced psychosis presents a distinct clinical profile that differs significantly from schizophrenia symptoms.
Space Travel Research Reveals New Insights Into Cancer Cell Biology
Scientists studying astronaut health data found that the conditions of space travel offer unexpected insights into how cancer cells behave and adapt.
Remibrutinib Resolves Chronic Inducible Urticaria in New Clinical Trial Data
New results from the EAACI 2026 congress showed remibrutinib effectively resolved chronic inducible urticaria, a difficult-to-treat allergic skin condition.
Poor Sleep in Midlife Tied to Worse Wellbeing and Cognitive Function Years Later
Research presented at SLEEP 2026 found that inadequate sleep during midlife was associated with significantly worse cognitive and emotional wellbeing in later years.
7 of 9 Planetary Boundaries Now Breached With Ocean Acidification Newest Crossing
India’s 2026 State of Environment report warns that ocean acidification has joined six other breached planetary boundaries threatening Earth’s stability.
AIIMS Study Shows Air Pollution Disrupts Foetal Growth Via Protein Suppression
An AIIMS Delhi study identified the molecular pathway through which PM2.5 air pollution suppresses a key protein needed for healthy foetal development.
India Cabinet Approves EV Scheme to Incentivise Trucks and Buses in NCR
The Union Cabinet approved a two-year scheme giving incentives for truck and bus owners in the National Capital Region to switch to electric or BS-VI vehicles.
Texas Screwworm Outbreak Prompts Release of Hundreds of Millions of Sterile Flies
Texas Governor Greg Abbott announced plans to release sterile screwworm flies to eradicate the parasite, which was first detected in a Texas calf on June 3.
Pembrolizumab Favoured Over Chemotherapy for Patients With Pulmonary Side Effects
New data at a 2026 conference showed pembrolizumab was associated with fewer pulmonary adverse events than chemotherapy for certain cancer patients.